| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-08 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-06 |